Yahoo Web Suche

Suchergebnisse

1. www.finanznachrichten.de › nachrichten-aktien › pumaPUMA BIOTECHNOLOGY AKTIEN News | A1J643 Nachrichten

   www.finanznachrichten.de › nachrichten-aktien › puma

   • Im Cache

   Vor einem Tag · Das Unternehmen PUMA BIOTECHNOLOGY INC kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell +3,44 % bei einem Aktienkurs von 3,126 Euro. Ich würde die...

2. stockanalysis.com › stocks › pbyiPuma Biotechnology, Inc. (PBYI) - Stock Analysis

   stockanalysis.com › stocks › pbyi

   • Im Cache

   Vor 6 Tagen · Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

3. www.investing.com › news › company-newsPuma Biotech expands stock incentive plan, shareholders approve

   www.investing.com › news › company-news

   • Im Cache

   24. Juni 2024 · Puma Biotechnology (NASDAQ: PBYI), Inc. has announced the approval of an amendment to its stock incentive plan, following a vote at the company's annual meeting.

4. www.boerse.de › aktien › Puma-Biotechnology-AktiePuma Biotechnology AKTIE | Aktienkurs & News - boerse.de

   www.boerse.de › aktien › Puma-Biotechnology-Aktie

   • Im Cache

   25. Juni 2024 · Puma Biotechnology AKTIE (ISIN: US74587V1070): Realtime-Kurs der Puma Biotechnology Aktie in EUR Analysen & Performance aktuelle Nachrichten ⇒ die nächsten Kursziele.

5. www.morningstar.com › stocks › xnasPBYI Stock Price Quote | Morningstar

   www.morningstar.com › stocks › xnas

   • Im Cache

   28. Juni 2024 · See the latest Puma Biotechnology Inc stock price (PBYI:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

6. simplywall.st › stocks › usPuma Biotechnology NasdaqGS:PBYI Stock Report - Simply Wall St

   simplywall.st › stocks › us

   • Im Cache

   Vor 5 Tagen · Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

7. www.biospace.com › article › releasesPuma Biotechnology Reports Inducement Awards Under Nasdaq ... -...

   www.biospace.com › article › releases

   • Im Cache

   2. Juli 2024 · Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral), in 2011.